BACKGROUND: Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications. OBJECTIVE: To assess temporal trends in late presentation for outpatient HIV medial care as measured by CD4 count <200 cells/mm(3) and the implications on short-term (1-year) mortality. DESIGN: We conducted a cohort study nested in a prospective HIV clinical cohort including patients establishing initial outpatient HIV treatment between 2000-2010. Time series regression analysis evaluated temporal trends in late presentation for care measured by the proportion of patients with a CD4 count <200 cells/mm(3) or an opportunistic infection at enrollment, and also evaluated trends in short-term mortality. PARTICIPANTS: Patients establishing initial outpatient HIV treatment between 2000-2010 at an academic HIV clinic. MAIN MEASURES: The proportion of patients with a CD4 count <200 cells/mm(3) or an opportunistic infection at initial presentation and short-term (1-year) mortality following clinic enrollment. KEY RESULTS: Among 1121 patients, 41% had an initial CD4 count <200 cells/mm(3), 25% had an opportunistic infection and 2.4% died within 1-year of their initial visit. Time series regression analysis demonstrated significant reductions in late presentation for HIV care and decreases in short-term mortality with temporal improvement preceding updated CDC HIV testing recommendations. CONCLUSION: We observed a significant decline in the number of patients presenting for outpatient HIV care with advanced disease, particularly in 2006-2010. A significant trend in improved short-term survival among patients establishing HIV care was also observed, likely related to more timely presentation for outpatient care in more recent years.
BACKGROUND: Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications. OBJECTIVE: To assess temporal trends in late presentation for outpatient HIV medial care as measured by CD4 count <200 cells/mm(3) and the implications on short-term (1-year) mortality. DESIGN: We conducted a cohort study nested in a prospective HIV clinical cohort including patients establishing initial outpatient HIV treatment between 2000-2010. Time series regression analysis evaluated temporal trends in late presentation for care measured by the proportion of patients with a CD4 count <200 cells/mm(3) or an opportunistic infection at enrollment, and also evaluated trends in short-term mortality. PARTICIPANTS: Patients establishing initial outpatient HIV treatment between 2000-2010 at an academic HIV clinic. MAIN MEASURES: The proportion of patients with a CD4 count <200 cells/mm(3) or an opportunistic infection at initial presentation and short-term (1-year) mortality following clinic enrollment. KEY RESULTS: Among 1121 patients, 41% had an initial CD4 count <200 cells/mm(3), 25% had an opportunistic infection and 2.4% died within 1-year of their initial visit. Time series regression analysis demonstrated significant reductions in late presentation for HIV care and decreases in short-term mortality with temporal improvement preceding updated CDC HIV testing recommendations. CONCLUSION: We observed a significant decline in the number of patients presenting for outpatient HIV care with advanced disease, particularly in 2006-2010. A significant trend in improved short-term survival among patients establishing HIV care was also observed, likely related to more timely presentation for outpatient care in more recent years.
Authors: Caroline A Sabin; Colette J Smith; Mike Youle; Fiona C Lampe; Di Robertson Bell; Dewi Puradiredja; Marc C I Lipman; Sanjay Bhagani; Andrew N Phillips; Margaret A Johnson Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark Journal: MMWR Recomm Rep Date: 2006-09-22
Authors: Ray Y Chen; Neil A Accortt; Andrew O Westfall; Michael J Mugavero; James L Raper; Gretchen A Cloud; Beth K Stone; Jerome Carter; Stephanie Call; Maria Pisu; Jeroan Allison; Michael S Saag Journal: Clin Infect Dis Date: 2006-02-22 Impact factor: 9.079
Authors: Jonathan M Ellen; Bill Kapogiannis; J Dennis Fortenberry; Jiahong Xu; Nancy Willard; Anna Duval; Jill Pace; Jackie Loeb; Dina Monte; James Bethel Journal: AIDS Date: 2014-05-15 Impact factor: 4.177
Authors: Kate Buchacz; Bryan Lau; Yuezhou Jing; Ronald Bosch; Alison G Abraham; M John Gill; Michael J Silverberg; James J Goedert; Timothy R Sterling; Keri N Althoff; Jeffrey N Martin; Greer Burkholder; Neel Gandhi; Hasina Samji; Pragna Patel; Anita Rachlis; Jennifer E Thorne; Sonia Napravnik; Keith Henry; Angel Mayor; Kelly Gebo; Stephen J Gange; Richard D Moore; John T Brooks Journal: J Infect Dis Date: 2016-04-18 Impact factor: 5.226
Authors: Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks Journal: Ann Intern Med Date: 2012-09-04 Impact factor: 25.391
Authors: Susan M Kiene; Seth C Kalichman; Katelyn M Sileo; Nicolas A Menzies; Rose Naigino; Chii-Dean Lin; Moses H Bateganya; Haruna Lule; Rhoda K Wanyenze Journal: BMC Infect Dis Date: 2017-07-03 Impact factor: 3.090